Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.945
-0.005 (-0.13%)
Jul 6, 2026, 3:51 PM EDT - Market open
Eledon Pharmaceuticals Employees
Eledon Pharmaceuticals had 33 employees as of December 31, 2025. The number of employees increased by 2 or 6.45% compared to the previous year.
Employees
33
Change (1Y)
2
Growth (1Y)
6.45%
Revenue / Employee
n/a
Profits / Employee
-$2,368,091
Market Cap
304.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 33 | 2 | 6.45% | 33 | 0 |
| Dec 31, 2024 | 31 | 11 | 55.00% | 31 | 0 |
| Dec 31, 2023 | 20 | 3 | 17.65% | 20 | 0 |
| Dec 31, 2022 | 17 | 5 | 41.67% | 17 | 0 |
| Dec 31, 2021 | 12 | 2 | 20.00% | 12 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| Adagene | 128 |
| Foghorn Therapeutics | 106 |
| Zentalis Pharmaceuticals | 106 |
| Neumora Therapeutics | 92 |
| SAB Biotherapeutics | 86 |
| Cartesian Therapeutics | 75 |
ELDN News
- 11 days ago - Natera, Eledon announce strategic partnership - TheFly
- 11 days ago - Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial - Business Wire
- 14 days ago - Eledon Pharmaceuticals Transcript: Study result - Transcripts
- 14 days ago - Eledon Pharmaceuticals Press release: Study result - Filings
- 14 days ago - Eledon Pharmaceuticals Slides: Study result - Filings
- 14 days ago - Eledon Pharmaceuticals announces new long-term data from BESTOW program - TheFly
- 14 days ago - Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus - GlobeNewsWire
- 4 weeks ago - Eledon Pharmaceuticals announces updated results from tegoprubart trial - TheFly